cimetidine

(redirected from Tagamet HB200)
Also found in: Thesaurus, Medical.
Related to Tagamet HB200: cimetidine

ci·met·i·dine

 (sĭ-mĕt′ĭ-dēn′, -dīn′)
n.
A histamine receptor antagonist, C10H16N6S, that inhibits acid secretion in the stomach and is used to treat duodenal and gastric ulcers and gastroesophageal reflux disease.

[Alteration of cy(ano-) + met(hyl) + (guan)idine.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

cimetidine

(saɪˈmɛtɪdiːn)
n
(Pharmacology) a drug used to suppress the formation of acid by the stomach and so to encourage the healing of gastric and duodenal ulcers. Formula: C10H16-N6S
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

ci•met•i•dine

(saɪˈmɛt ɪˌdin)

n.
a substance, C10H16N6S, used for inhibiting gastric secretion in the treatment of duodenal ulcers.
[1975–80; probably ci-, resp. of cy(ano)-2 + met(hyl) + (guan)idine]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.cimetidine - a drug (trade name Tagamet) used to treat peptic ulcers by decreasing the secretion of stomach acid
histamine blocker - a medicine used to treat the gastric effects of histamine in cases of peptic ulcers and gastritis and gastroesophageal reflux; works by blocking the effects of histamine on the receptor site known as H2
alkaliser, alkalizer, antacid, antiacid, gastric antacid - an agent that counteracts or neutralizes acidity (especially in the stomach)
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
References in periodicals archive ?
dose form (SmithKline Beecham PLC's Tagamet HB200 tablets) and cefadroxil tablets in 1-gram dosage strength (Bristol-Meyers Squibb Co.'s Duricef).
SmithKline Beecham 8.2% 87,440 Tagamet HB200 SmithKline Beecham 7.0% 74,862 Tums SmithKline Beecham 5.8% 62,124 Rolaids Warner-Lambert 5.2% 55,636 GasX Novartis 4.0% 42,576 Tum Ultra SmithKline Beecham 3.8% 40,049 Phazyme Block Drug 2.7% 28,432 Gaviscon SmithKline Beecham 2.4% 25,642 For the 52 weeks through March 28, 1999.